BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
88 hedge funds and large institutions have $212M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $216M → $212M (-$3.89M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
88
Holding in Top 10
–
Calls
$3.59M
Puts
$1.89M
Top Buyers
| 1 | +$4.72M | |
| 2 | +$1.72M | |
| 3 | +$1.63M | |
| 4 |
Morgan Stanley
New York
|
+$1.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.15M |
Top Sellers
| 1 | -$5.29M | |
| 2 | -$2.92M | |
| 3 | -$2.36M | |
| 4 |
Millennium Management
New York
|
-$1.49M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.24M |